HY-103663-10mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-103663-100mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-103663-25mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-103663-5mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-103663-50mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-116215-1mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-10mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-100mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-25mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-5mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-50mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-129547-1mg
|
MedChemexpress LLC
|
Fluo-3 (pentapotassium) [CAS 853400-67-6]
|
|
|
|
HY-131008-1mg
|
MedChemexpress LLC
|
Fluorescein tyramide [CAS 210236-90-1]
|
|
|
|
HY-131008-10mg
|
MedChemexpress LLC
|
Fluorescein tyramide [CAS 210236-90-1]
|
|
|
|
HY-131008-5mg
|
MedChemexpress LLC
|
Fluorescein tyramide [CAS 210236-90-1]
|
|
|
|
HY-15928-1g
|
MedChemexpress LLC
|
PNPP (disodium) [CAS 4264-83-9]
|
|
|
|
HY-15928-5g
|
MedChemexpress LLC
|
PNPP (disodium) [CAS 4264-83-9]
|
|
|
|
HY-15928-500mg
|
MedChemexpress LLC
|
PNPP (disodium) [CAS 4264-83-9]
|
|
|
|
HY-15930-1g
|
MedChemexpress LLC
|
TMB [CAS 54827-17-7]
|
|
|
|
HY-15930-5g
|
MedChemexpress LLC
|
TMB [CAS 54827-17-7]
|
|
|
|
HY-15930-500mg
|
MedChemexpress LLC
|
TMB [CAS 54827-17-7]
|
|
|
|
HY-15930A-1g
|
MedChemexpress LLC
|
TMB (dihydrochloride) [CAS 64285-73-0]
|
|
|
|
HY-15930A-5g
|
MedChemexpress LLC
|
TMB (dihydrochloride) [CAS 64285-73-0]
|
|
|
|
HY-15930A-500mg
|
MedChemexpress LLC
|
TMB (dihydrochloride) [CAS 64285-73-0]
|
|
|
|
HY-15930C-100mg
|
MedChemexpress LLC
|
TMB (monosulfate) [CAS 54827-18-8]
|
|
|
|